Ticker LaunchReverse merger · Completed · BRGX
BioRegenx, Inc.
Reverse merger with Findit, Inc. (FDIT)
BioRegenx, Inc. merged into Findit, Inc. (FDIT), a OTC Pink-listed public company, in a reverse merger that takes the private company public. It closed on Mar 8, 2024. The combined company trades as BioRegenx, Inc. (BRGX) on OTC.
- Status
- Completed
- Private company
- BioRegenx, Inc.
- Public company
- Findit, Inc. (FDIT)
- Public company business before
- OTC Pink-listed public company
- Closed
- Mar 8, 2024
- Combined company
- BioRegenx, Inc. (BRGX)
- Exchange
- OTC
- Sector
- Consumer
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Apr 1, 2024
- Closing press release
- All filings on EDGAR CIK 1593184
Other completed reverse mergers
- Trawsfynydd Therapeutics, Inc.into Onconova Therapeutics, Inc. · Apr 1, 2024
- Serina Therapeutics, Inc.into AgeX Therapeutics, Inc. · Mar 26, 2024
- Q32 Bio Inc.into Homology Medicines, Inc. · Mar 25, 2024
- LENZ Therapeutics (LENZ OpCo)into Graphite Bio, Inc. · Mar 21, 2024
- Emergent Health Corp.into Resonate Blends, Inc. · Mar 14, 2024
- XTI Aircraft Companyinto Inpixon · Mar 12, 2024